Alzheimer’s Disease Management: Current Therapy and Recent Drug Development
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 7, Issue 2
Abstract
Alzheimer’s disease is an age-related central nervous disorder that has created daunting challenges for the treating physicians, the families and the society. Alzheimer’s disease, a leading neurodegenerative disorder worldwide, is a major cause of dementia in the developed and developing countries around the globe. While, there is no definitive cure for Alzheimer’s disease and no treatment is available to reverse or halt its progression. Currently Food Drug Administration approved acetylcholinesterase inhibitors and memantine, a N-methyl-D-aspartate receptor antagonist for the treatment of Alzheimer’s disease. Moreover, new therapeutic approaches, including those more closely targeted to the pathogenesis of the disease, are being developed. This potentially disease-modifying therapeutics includes both beta and gamma secretase inhibitors, cholesterol-lowering drugs, amyloid-beta immunotherapy, non-steroidal anti-inflammatory drugs, hormonal modulation and the use of antioxidants. In this current review we summarize the available evidences on the newer therapeutic approaches for the treatment of Alzheimer’s disease.
Authors and Affiliations
Md. Shamshir Alam, Mohammad Yaseen Abbasi
Keywords
Related Articles
- EP ID EP241862
- DOI 10.9734/INDJ/2016/24771
- Views 116
- Downloads 0
Reversible Diffusion Restriction is Not Always Correlated with Clinical Recovery in Hypoglycemic Encephalopathy
An 84-year-old female patient presented to our emergency department with unconsciousness. She was diabetic and the blood level of glucose was 34 mg/dL. Diffusion-weighted images (DWI) revealed symmetrical hyperintensity...
The Spectrum of Herpesvirus Infections of the Nervous System in Adult Patients in Ukraine: A Prospective Single Center Study
Background: Herpesviruses (HVs) are ubiquitous pathogens that infect humans usually during childhood, followed by a life-long persistence in a latent state in many sites of a body including the nerve cells. After reactiv...
Depression and Disability in Chronic Kidney Disease in Nigeria: A Case-Control Study
Aim: The main purpose of this study was to determine the prevalence of depression and disability in Chronic Kidney Disease (CKD) patients and to determine any association between stage of CKD and depression in the Univer...
Prevalence of Diabetes Mellitus among Psychotropic Drug Naive Patients with Psychiatric Disorders at Federal Neuro-Psychiatric Hospital Barnawa, Kaduna
Background: It has been established that diabetes mellitus occurs frequently among psychiatric patients; however, little is known about diabetes mellitus among psychotropic drug naive patients with psychiatric disorders...
Mental Health Issues in Multiple Sclerosis Patients and Healthy Controls and Their Association with Disease Related Factors
Purpose: To investigate the mental health problems of multiple sclerosis (MS) patients, and the relationship between mental health, MS variables and disability status. Methods: The sample consisted of 80 participants, 4...